Xometry (NASDAQ:XMTR) Price Target Lowered to $30.00 at JPMorgan Chase & Co.

Xometry (NASDAQ:XMTRFree Report) had its price target cut by JPMorgan Chase & Co. from $45.00 to $30.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have an overweight rating on the stock.

Several other brokerages have also recently issued reports on XMTR. Citigroup reduced their price target on shares of Xometry from $46.00 to $39.00 and set a “buy” rating on the stock in a research report on Thursday, February 27th. JMP Securities reiterated a “market outperform” rating and issued a $42.00 target price on shares of Xometry in a report on Monday, February 10th. UBS Group upped their price target on Xometry from $22.00 to $33.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. Royal Bank of Canada lifted their price objective on Xometry from $27.00 to $40.00 and gave the company a “sector perform” rating in a research note on Friday, January 3rd. Finally, Cantor Fitzgerald upped their target price on shares of Xometry from $12.00 to $20.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Xometry currently has a consensus rating of “Moderate Buy” and a consensus price target of $34.44.

Check Out Our Latest Stock Analysis on XMTR

Xometry Trading Up 5.2 %

Shares of NASDAQ XMTR opened at $23.34 on Tuesday. The stock has a fifty day simple moving average of $25.68 and a 200-day simple moving average of $29.46. Xometry has a twelve month low of $11.08 and a twelve month high of $45.33. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. The stock has a market capitalization of $1.17 billion, a PE ratio of -22.23 and a beta of 0.72.

Insider Activity

In related news, CFO James Miln sold 1,346 shares of the company’s stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $25.13, for a total value of $33,824.98. Following the completion of the sale, the chief financial officer now owns 144,713 shares in the company, valued at $3,636,637.69. This represents a 0.92 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Emily Rollins sold 2,000 shares of the firm’s stock in a transaction on Monday, April 7th. The stock was sold at an average price of $20.66, for a total transaction of $41,320.00. Following the transaction, the director now directly owns 16,146 shares in the company, valued at $333,576.36. The trade was a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 78,256 shares of company stock valued at $2,012,889. Insiders own 16.79% of the company’s stock.

Institutional Investors Weigh In On Xometry

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in shares of Xometry by 2.1% during the fourth quarter. Vanguard Group Inc. now owns 4,293,272 shares of the company’s stock worth $183,151,000 after purchasing an additional 86,997 shares during the last quarter. Sylebra Capital LLC raised its position in Xometry by 2.1% during the 4th quarter. Sylebra Capital LLC now owns 1,834,750 shares of the company’s stock worth $78,270,000 after buying an additional 37,883 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Xometry by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 1,004,452 shares of the company’s stock worth $42,861,000 after acquiring an additional 8,974 shares during the period. State Street Corp boosted its holdings in shares of Xometry by 0.3% in the third quarter. State Street Corp now owns 887,139 shares of the company’s stock valued at $16,297,000 after acquiring an additional 3,027 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of Xometry by 225.7% during the fourth quarter. Ameriprise Financial Inc. now owns 852,813 shares of the company’s stock worth $36,381,000 after acquiring an additional 590,974 shares during the period. Institutional investors and hedge funds own 97.31% of the company’s stock.

About Xometry

(Get Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Further Reading

Analyst Recommendations for Xometry (NASDAQ:XMTR)

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.